Company Overview and News

Stop missing out on important events!

Fintel provides real time notifications of important company events such as major investments (13D/G filings), insider trades (SEC form 4), and important SEC filings. Sign up and create your company alerts for free.

Headline News

PolyNovo to jointly develop medical devices for use in breast surgery

PolyNovo Ltd (ASX:PNV) has signed an agreement with Establishment Labs to jointly develop a range of medical devices for use in breast surgery.

Polynovo signs deal to launch its skin regeneration technology in Israel

Polynovo Ltd (ASX:PNV) has signed a distribution agreement with AMI Medical Technologies in Israel for its NovoSorb™ BTM tissue scaffold used for skin regeneration.

Polynovo follows swift re-rating with a capital raising

Polynovo Ltd's (ASX:PNV) shares last traded at $0.285, or around 60% higher than a month ago, with the company receiving a positive re-rating following its first U.S. sales of NovoSorb BTM™

Polynovo Ltd to divulge funding for non-clinical trial

PolyNovo (ASX:PNV) is a Melbourne-based regenerative medical device company that designs, develops and manufactures devices using its patented NovoSorb™ biodegradable polymer technology.

Release of shares from escrow


Appendix 3B


Appendix 3B


Half Yearly Report and Accounts


Financial Result Guidance